Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ADI PEG20 × Other solid neoplasm × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Dermatologic 1 CNS 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 39 Pemetrexed 29 Carboplatin 23 Nivolumab 19 Gemcitabine 18 pembrolizumab 16 atezolizumab 13 Ipilimumab 10 Injections 10 Docetaxel 10 Cyclophosphamide 10 Bevacizumab 10 Radiotherapy 9 Oxaliplatin 9 Etoposide 9 tislelizumab 8 durvalumab 8 Specimen Handling 8 Paclitaxel 8 Filgrastim 8 Capecitabine 8 tremelimumab 7 lenvatinib 7 olaparib 6 niraparib 6 Vinorelbine 6 Vincristine 6 Immune Checkpoint Inhibitors 6 Biopsy 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279967 2014-11-20

ADAM

Barts & The London NHS Trust

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡